trending Market Intelligence /marketintelligence/en/news-insights/trending/IhTjcEJUlmjyt3kjIF9D_A2 content esgSubNav
In This List

Catalyst plans common stock offering

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Catalyst plans common stock offering

Catalyst Biosciences Inc. plans to offer common shares in an underwritten public offering.

Net proceeds will be used for general corporate purposes, including clinical trials, research and development activities, capital expenditures, selling, general and administrative costs, facilities expansion, and to meet working capital needs.

JonesTrading Institutional Services LLC and Ladenburg Thalmann & Co. Inc. are acting as joint book-running managers. LifeSci Capital LLC is acting as a co-manager for the proposed offering.